Evidence·Exposure / Absorption
ReportedCmax evidence
ATLXM0054454
A single reference-linked measurement — its measured value, assay/model context, and interpretation layer kept separate.
Stack
ATLXM0054454
A single reference-linked measurement — its measured value, assay/model context, and interpretation layer kept separate.
ATLXM0054454
Carfilzomib at doses between 20 mg/m 2 and 70 mg/m 2 administered as a 30-minute infusion resulted in dose-dependent increases in maximum plasma concentrations (C max ) and area under the curve over time to infinity (AUC 0-INF ) in patients with multiple myeloma.
This page treats the row as evidence attached to an endpoint and assay context. The layer describes how the row can be interpreted; it is not a safety or developability score by itself.
